Navigation Links
Virginia Woolf and Neuropsychiatry
Date:1/25/2013

Virginia Woolf and Neuropsychiatry, written by Maxwell Bennett, one of the leaders in the field of neurosciences, provides an explanation of the symptoms and untimely suicide of one of literature's greatest authors, Virginia Woolf. The sources used are letters and statements from Woolf herself, the literature she wrote and comments, letters and other documentation that refers to her mental state and her medical status. The author uses current insights into depression, the mental consequences of child abuse and drug interactions/effects to examine her life.

The second part of the book provides a neuropsychiatric analysis of the state of present knowledge concerning what goes awry in the functioning of the brain in depression, particularly leading to suicide. Five essays, aimed at specialists in neuropsychiatry, show how far we have probed brain functions related to major psychiatric problems.

Maxwell Bennett said: "Because of her literary genius, we find in her novels, plays, critical reviews, autobiographical sketches and diaries an unparalleled insight into the mind of someone destined to end their life. These offer those concerned with mitigating the incidence of suicide a unique opportunity to consider the circumstances and familial burdens that promote severe depression and so design programs that will ameliorate them."

M. R. Bennett AO is Professor of Neuroscience and University Chair at the University of Sydney, Founding Director of the Brain and Mind Research Institute and Adjunct Professor of Neuropsychiatry. He is the author of many papers and books in neuroscience and neuropsychiatry, including The Idea of Consciousness (1997) and a History of the Synapse (2001) as well as more recently Philosophical Foundations of Neuroscience (2003) and History of Cognitive Neuroscience (2008) with his colleague Peter Hacker. Maxwell Bennett is the recipient of numerous awards for his research in neuroscience.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert  

Page: 1

Related biology news :

1. Virginia Tech computer scientists develop new way to study molecular networks
2. TESARO and Virginia G. Piper Cancer Center announce first patient in clinical trial of TSR-011
3. Old deeds, witness trees offer glimpse of pre-settlement forest in West Virginia
4. Scientific meeting at Virginia Tech will make more than $2 million economic impact
5. Virginia Tech and University of Tuscia lead team to unravel origin of devastating kiwifruit bacterium
6. Biology professor secures grant to save West Virginias primary natural history collection
7. Virginia Tech announces 2012 football helmet ratings; 2 more added to the 5-star mark
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Virginia Woolf and Neuropsychiatry
(Date:6/30/2017)... June 30, 2017 Today, American Trucking ... supplier of face and eye tracking software, became ... provider program. "Artificial intelligence and ... to monitor a driver,s attentiveness levels while on ... able to detect fatigue and prevent potential accidents, ...
(Date:5/16/2017)... 16, 2017   Bridge Patient Portal , ... MD EMR Systems , an electronic medical ... GE, have established a partnership to build an ... the GE Centricity™ products, including Centricity Practice Solution ... These new integrations will allow healthcare delivery ...
(Date:4/17/2017)... MELBOURNE, Florida , April 17, 2017 ... security technology company, announces the filing of its 2016 Annual Report ... Securities and Exchange Commission. ... Report on Form 10-K is available in the Investor Relations section ... well as on the SEC,s website at http://www.sec.gov . ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th ... in San Francisco, CA. The Summit brings together current and former FDA office bearers, ... and government officials from around the world to address key issues in device compliance, ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
(Date:10/10/2017)... Philadelphia, PA (PRWEB) , ... October 10, 2017 ... ... University City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. ... accept the award for Excellence in Volunteer Experience from US2020. , US2020’s mission ...
Breaking Biology Technology: